Kaitlyn Landi

Contracting Specialist National Institute on Drug Abuse (NIH)

Email
kaitlyn.landi@nih.gov
Phone
(301) 827-1804
Latest SAM.gov record

Contact facts

SAM.gov notices
38
First SAM.gov record

Notices come from SAM.gov.

SAM.gov notices

Notice Posted
MMA-101 Stability and Compatibility Studies and CMC Solicitation
CSS: Bioanalytical Assay Methods Development and Performance for the Evaluation of Safety and Efficacy of an AAV-Based Gene Therapy Candidate in Methyl Malonic Acidemia (MMA) disease Solicitation
Notice of Intent to Sole Source: Covalent screening library of small molecules (500 from Sulfamoyl fluorides set and 500 from Cyanamides set) Special Notice
Notice of Intent to Sole Source: Service/maintenance agreement for the Agilent G6546 LC-QTOF system in the ACC group at NCATS Special Notice
Service/Maintenance Agreement for the Lab2Lab pneumatic tubing system Special Notice
Notice of Intent to Sole Source: Viralgen stability timepoints data Special Notice
Notice of Intent to Sole Source: Renewal of comprehensive database of information on pharmaceuticals Software License regarding drugs, diseases, pharmacological data, pathway interaction and relevant patents. Special Notice
Small molecule screening guided by AI derived computational analyses in colon and ovarian tumors Special Notice
Reagent Generation for Bioanalytical Method Development on Biologics Pre-Solicitation
UPS Power and Battery Services (Brand-name or equal) Award Notice · 75N95024C00043
Phase 2 of Research Support Services for the Impact of Rare Diseases on Patients and Healthcare Systems (IDeaS) initiative Pilot Program Solicitation
UPS Power and Battery Services (Brand-name or equal) Solicitation · 75N95024R00120
CSS: Whole genome sequencing for HANDLS participants Solicitation
Verily Workbench License Data Sharing Platform (Brand-name or equal) Solicitation
Notice of Intent to Sole Source: FCDI iCell Neurons and supplements for neurotoxicity screening Special Notice
Small Business Sources Sought: Verily Workbench License Data Sharing Platform Pre-Solicitation
Sources Sought: Verily Workbench License Data Sharing Platform Pre-Solicitation
Notice of Intent to Sole Source: Immunoproteomic Profiles of Autoimmunity in Hispanic Populations Special Notice
Small Business Sources Sought: Whole genome sequencing for HANDLS participants Pre-Solicitation
Sources Sought: Whole genome sequencing for HANDLS participants Pre-Solicitation
Notice of Intent to Sole Source: non-GMP scale up synthesis of (4-(1-(3-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)(4-((3-fluorobenzyl)oxy)-3-methoxyphenyl)methanone Special Notice
Notice of Intent to Sole Source: Service/Maintenance Agreement for the Biacore S200 SPR-based sensor, AKTA Pure 25, and AKTA Purifier 10 Systems Special Notice
Notice of Intent to Sole Source: Promega Reagent Kits and Assays Special Notice
Notice of Intent to Sole Source: Thermo Fisher Lipofectamine RNAiMAX Transfection Reagent Special Notice
Notice of Intent to Sole Source: Repair of two (2) SPT Labtech Acumen microplate cell cytometers Special Notice
Show 15 more

Latest 25 of 38 listed here. See the rest on GovTribe.

Top NAICS codes

Top PSC codes

Quick answers

Who is Kaitlyn Landi?

Kaitlyn Landi is a Contracting Specialist at National Institute on Drug Abuse (National Institutes of Health). Point of contact on 38 SAM.gov notices, from April 12, 2024 to May 5, 2025.

How do I contact Kaitlyn Landi?

SAM.gov lists Kaitlyn Landi's email kaitlyn.landi@nih.gov and phone (301) 827-1804.

What is the latest SAM.gov notice naming Kaitlyn Landi?

MMA-101 Stability and Compatibility Studies and CMC, solicitation, posted May 5, 2025.

On GovTribe

See Kaitlyn Landi's full record

  • Every notice, award and file that names them
  • Their buying profile: what they buy and from whom
  • Export contacts at this office
  • Ask GovTribe AI about this contact